Researchers from the UK found that vaccination with the first doses of Astrazeneca and Pfizer drugs increases the risk of hemorrhage into the brain, as well as the development of such neurological diseases as Guillana Barre syndrome and Bella Paralysis. At the same time, the scientists are emphasized, whose article is published in the journal Nature Medicine, the risk of neurological complications in infecting COVID-19 is much higher.
A group of British researchers led by specialists from Oxford University rated information about the health of 32 million British, who received the first dose of Astrazeneca or Pfizer on December 1, 2020 to March 31, 2021. Scientists trained in their cases of neurological complications until the 28th day after receiving the dose. It turned out that among vaccinated by Astrazeneca slightly increased risk of developing Hyien-Barre syndrome (38 redundant cases for ten million people) and Bella paralysis for 15-21 days after vaccination. For those who were given Pfizer, there was a higher risk of hemorrhage into the brain – 60 redundant cases for ten million people.
At the same time, among the more than more than two million people of the total number who have contracted the coronavirus infection, the risk of all seven track the neurological complications was significantly higher. Ten million people, there were 123 excess cases of encephalitis, meningitis and myelitis, 163 additional cases and 145 myasthenic disorders – Guillain-Barré syndrome. The researchers further confirmed their findings on a cohort of almost two million vaccinated the Scots.